<story><title>Zantac’s maker kept quiet about cancer risks for 40 years</title><url>https://www.fiercepharma.com/pharma/gsk-was-warned-repeatedly-about-zantac-risks-didnt-act-warnings-bloomberg</url></story><parent_chain></parent_chain><comment><author>bsuvc</author><text>It&amp;#x27;s not just that it causes cancer, but it&amp;#x27;s that improper storage (heat exposure) increases the risk of it causing cancer, and when informed of that, GSK decided it was not worth doing anything about it.&lt;p&gt;&amp;gt; GSK&amp;#x27;s leadership was warned on several occasions about the storage issue, but it opted against making any changes to existing plans.&lt;p&gt;In a way, this makes it worse, because they could have taken action to limit the risk to people, but chose not to, presumably to save money or to avoid bad publicity.</text></comment>
<story><title>Zantac’s maker kept quiet about cancer risks for 40 years</title><url>https://www.fiercepharma.com/pharma/gsk-was-warned-repeatedly-about-zantac-risks-didnt-act-warnings-bloomberg</url></story><parent_chain></parent_chain><comment><author>mysterypie</author><text>&amp;gt; &lt;i&gt;Intense public scrutiny on Zantac started in 2019, when an online pharmacy found high levels of a likely carcinogen in the drug and its generics.&lt;/i&gt;&lt;p&gt;And the linked article says:&lt;p&gt;&amp;gt; &lt;i&gt;Valisure discovered the link of Zantac and its generics to the carcinogen NDMA during its routine testing of every batch of every medication, and first notified the FDA of its initial findings in June of 2019.  On September 13th, Valisure filed a detailed petition with the Food and Drug Administration asking the agency to recall all products containing ranitidine.&lt;/i&gt;&lt;p&gt;How in the world is it profitable for an online pharmacy to do this? It&amp;#x27;s great, but honestly who would pay extra to an online pharmacy to do this testing? Would most people even believe an online pharmacy that said that they did such testing? I&amp;#x27;d love to know how they survive.</text></comment>